GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (LTS:0QYW) » Definitions » Cyclically Adjusted Revenue per Share

Bausch Health (LTS:0QYW) Cyclically Adjusted Revenue per Share : CHF432.20 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bausch Health's adjusted revenue per share for the three months ended in Dec. 2023 was CHF5.688. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF432.20 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Bausch Health's average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 15.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bausch Health was 24.90% per year. The lowest was 4.10% per year. And the median was 12.25% per year.

As of today (2024-05-02), Bausch Health's current stock price is CHF122.93991. Bausch Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was CHF432.20. Bausch Health's Cyclically Adjusted PS Ratio of today is 0.28.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 27.37. The lowest was 0.17. And the median was 1.26.


Bausch Health Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted Revenue per Share Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.25 131.27 111.36 508.97 432.20

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 508.97 403.96 426.11 408.99 432.20

Competitive Comparison of Bausch Health's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted PS Ratio falls into.



Bausch Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=5.688/125.4675*125.4675
=5.688

Current CPI (Dec. 2023) = 125.4675.

Bausch Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 4.959 98.604 6.310
201406 5.357 99.473 6.757
201409 5.645 99.394 7.126
201412 6.342 98.367 8.089
201503 6.192 99.789 7.785
201506 7.395 100.500 9.232
201509 7.721 100.421 9.647
201512 7.877 99.947 9.888
201603 6.747 101.054 8.377
201606 6.801 102.002 8.366
201609 6.903 101.765 8.511
201612 7.005 101.449 8.664
201703 6.026 102.634 7.367
201706 6.175 103.029 7.520
201709 6.062 103.345 7.360
201712 6.048 103.345 7.343
201803 5.393 105.004 6.444
201806 5.997 105.557 7.128
201809 5.884 105.636 6.989
201812 5.978 105.399 7.116
201903 5.742 106.979 6.734
201906 6.039 107.690 7.036
201909 6.210 107.611 7.240
201912 6.196 107.769 7.214
202003 5.462 107.927 6.350
202006 4.455 108.401 5.156
202009 5.467 108.164 6.342
202012 5.524 108.559 6.384
202103 5.282 110.298 6.008
202106 5.319 111.720 5.974
202109 5.352 112.905 5.948
202112 5.617 113.774 6.194
202203 4.941 117.646 5.270
202206 5.269 120.806 5.472
202209 5.480 120.648 5.699
202212 5.634 120.964 5.844
202303 4.952 122.702 5.064
202306 5.315 124.203 5.369
202309 5.510 125.230 5.520
202312 5.688 125.468 5.688

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bausch Health  (LTS:0QYW) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bausch Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=122.93991/432.2
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bausch Health was 27.37. The lowest was 0.17. And the median was 1.26.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bausch Health Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (LTS:0QYW) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (LTS:0QYW) Headlines

No Headlines